Split History
ETFs Holding ALVR »    ALVR Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent viral diseases. Co.'s key product candidate, Viralym-M, is a multi-VST therapy targeting five viruses: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. ALVR106 is Co.'s second multi-virus-targeted off-the-shelf VST product candidate that it developed to target respiratory diseases. ALVR109 is an allogeneic, off-the-shelf single virus-targeted cell therapy designed to target SARS-CoV-2. Co. is also developing ALVR107 designed to target hepatitis B, or HBV, infected cells and treat chronic HBV infections and ALVR108 to treat human herpesvirus-8. According to our ALVR split history records, AlloVir has had 1 split.
ALVR split history picture
AlloVir (ALVR) has 1 split in our ALVR split history database. The split for ALVR took place on April 02, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of ALVR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as AlloVir conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ALVR split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AlloVir shares, starting with a $10,000 purchase of ALVR, presented on a split-history-adjusted basis factoring in the complete ALVR split history. ALVR split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/30/2020
End date: 12/03/2021
Start price/share: $25.39
End price/share: $17.49
Dividends collected/share: $0.00
Total return: -31.11%
Average Annual Total Return: -24.20%
Starting investment: $10,000.00
Ending investment: $6,888.59
Years: 1.35
Date Ratio
04/02/20131 for 10
ALVR is categorized under the Technology sector; below are some other companies in the same sector that also have a history of stock splits:

AMAT Split History
AMCC Split History
AMD Split History
AMRH Split History
AMSWA Split History
AMX Split History
ANAD Split History
ANEN Split History
ANET Split History
ANLY Split History

Email EnvelopeFree ALVR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Equitable Group Inc. (EQB.CA)
U.S. Well Services (USWS)
InMode Ltd. (INMD)
Sonim Technologies, Inc. (SONM)
AzurRx BioPharma, Inc. (AZRX)
Jaguar Health, Inc. (JAGX)
Microchip Technology Incorporated (MCHP)
ATIF Holdings Limited (ATIF)
Intuitive (ISRG)
Transportation Services, Inc. (PTSI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ALVR Insider Buying

ALVR Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.